These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 35764443)
1. Clinical outcome of combined intracavitary / interstitial brachytherapy using a hybrid applicator in locally advanced cervical cancer. Rogowski P; Rottler M; Walter F; Saicic S; Niyazi M; Well J; Nierer L; Trillsch F; Burges A; Mahner S; Belka C; Corradini S Gynecol Oncol; 2022 Sep; 166(3):576-581. PubMed ID: 35764443 [TBL] [Abstract][Full Text] [Related]
2. MRI-guided adaptive brachytherapy for locally advanced cervix cancer: Treatment outcomes from a single institution in Hong Kong. Wu PY; Wong TPW; Yip YYC; Chang TYA; Chan LKL; Lee MCH; Law LYA; Yeung MWR; Soong SI Brachytherapy; 2019; 18(2):171-179. PubMed ID: 30581053 [TBL] [Abstract][Full Text] [Related]
3. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients. Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510 [TBL] [Abstract][Full Text] [Related]
4. Combined intracavitary and interstitial brachytherapy of cervical cancer using the novel hybrid applicator Venezia: Clinical feasibility and initial results. Walter F; Maihöfer C; Schüttrumpf L; Well J; Burges A; Ertl-Wagner B; Mahner S; Belka C; Gallwas J; Corradini S Brachytherapy; 2018; 17(5):775-781. PubMed ID: 29941345 [TBL] [Abstract][Full Text] [Related]
5. Interstitial round needles should not be used for cervical cancer patient treated with intracavitary/ interstitial brachytherapy using a Venezia applicator : a case report. Takagawa Y; Izumi S; Takahashi E; Kita M BMC Womens Health; 2024 Apr; 24(1):249. PubMed ID: 38637783 [TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of single insertion accelerated MR-image guided brachytherapy following chemo-radiation in locally advanced cervix cancer: modifying our EMBRACE during the COVID pandemic. Stevens MJ; Ko F; Martland J; Brown R; Bell L; Atyeo J; Yim J Radiat Oncol; 2023 Mar; 18(1):54. PubMed ID: 36941643 [TBL] [Abstract][Full Text] [Related]
7. Outcomes and comparison of dosimetric parameters between intracavitary (Fletcher) and combined intracavitary/interstitial (Utrecht) brachytherapy in locally advanced cervical cancer. Sarwar KA; Hussain S; Syed AS; Khan K; Maqsood T; Azeem T Brachytherapy; 2024; 23(1):10-17. PubMed ID: 37813708 [TBL] [Abstract][Full Text] [Related]
8. Early outcomes and impact of a hybrid IC/IS applicator for a new MRI-based cervical brachytherapy program. Harkenrider MM; Surucu M; Harmon G; Mysz ML; Shea SM; Yacoub J; Goldberg A; Liotta M; Winder A; Potkul R; Roeske JC; Small W Brachytherapy; 2018; 17(1):187-193. PubMed ID: 29089277 [TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy and toxicity of radio-chemotherapy and magnetic resonance imaging-guided brachytherapy for locally advanced cervical cancer patients: A mono-institutional experience. Lakosi F; de Cuypere M; Viet Nguyen P; Jansen N; Warlimont B; Gulyban A; Gennigens C; Seidel L; Delbecque K; Coucke P; Hermesse J; Kridelka F Acta Oncol; 2015; 54(9):1558-66. PubMed ID: 26406152 [TBL] [Abstract][Full Text] [Related]
10. Interstitial needles versus intracavitary applicators only for locally advanced cervical cancer: results from real-life dosimetric comparisons. Cordoba A; Gesta E; Escande A; Noeuveglise A; Cayez R; Halty A; Ladjimi MT; Narducci F; Hudry D; Martinez Gomez C; Cordoba S; Le Deley MC; Barthoulot M; Lartigau EF Front Oncol; 2024; 14():1347727. PubMed ID: 38567146 [TBL] [Abstract][Full Text] [Related]
11. Vienna-II ring applicator for distal parametrial/pelvic wall disease in cervical cancer brachytherapy: An experience from two institutions: Clinical feasibility and outcome. Mahantshetty U; Sturdza A; Naga Ch P; Berger D; Fortin I; Motisi L; Schmid MP; Aravindakshan D; Ghadi Y; Swamidas JV; Chopra S; Gurram L; Nesvacil N; Kirisits C; Pötter R Radiother Oncol; 2019 Dec; 141():123-129. PubMed ID: 31495516 [TBL] [Abstract][Full Text] [Related]
12. Long-term effectiveness and safety of image-based, transperineal combined intracavitary and interstitial brachytherapy in treatment of locally advanced cervical cancer. Tiwari R; Narayanan GS; Narayanan S; Suresh Kumar P Brachytherapy; 2020; 19(1):73-80. PubMed ID: 31813739 [TBL] [Abstract][Full Text] [Related]
13. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer. Assenholt MS; Vestergaard A; Kallehauge JF; Mohamed S; Nielsen SK; Petersen JB; Fokdal L; Lindegaard JC; Tanderup K Brachytherapy; 2014; 13(4):361-8. PubMed ID: 24656732 [TBL] [Abstract][Full Text] [Related]
14. Image-guided adaptive brachytherapy for advanced cervical cancer spreading to the bladder and/or rectum: Clinical outcome and prognostic factors. Ka K; Laville A; Rassy E; Ayachi RE; Pautier P; Ba MB; Bockel S; Achkar S; Espenel S; Maulard A; Morice P; Gouy S; Haie-Meder C; Sun R; Chargari C Gynecol Oncol; 2023 Jan; 168():32-38. PubMed ID: 36370612 [TBL] [Abstract][Full Text] [Related]
15. Characterization of combined intracavitary/interstitial brachytherapy including oblique needles in locally advanced cervix cancer. Serban M; Fokdal L; Nielsen SK; Hokland SB; Hansen AT; Spejlborg H; Rylander S; Petric P; Lindegaard JC; Tanderup K Brachytherapy; 2021; 20(4):796-806. PubMed ID: 33994344 [TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes of conventional HDR intracavitary brachytherapy combined with complementary applicator-guided intensity modulated radiotherapy boost in patients with bulky cervical tumour. Lu S; Wang S; Kim RY; Zhang J; Wang X; Wang W; Zhu G; Zhou J; Tan Y; Tan M; Li M; Yin G; Li J; Feng M; Lang J BJOG; 2023 Jan; 130(2):231-237. PubMed ID: 36330947 [TBL] [Abstract][Full Text] [Related]